BioCardia regains Nasdaq minimum bid-price compliance
BioCardia said it regained compliance with Nasdaq's $1.00 minimum bid-price requirement after 10 consecutive business days at or above $1.00.
BioCardia said it regained compliance with Nasdaq's $1.00 minimum bid-price requirement after 10 consecutive business days at or above $1.00.